three
quarter
recent
discov
human
pathogen
viral
rna
virus
emerg
virus
hiv
sar
coronaviru
sarscov
capabl
caus
epidem
human
diseas
rna
viru
popul
sustain
high
genet
divers
due
low
fidel
polymeras
short
genom
high
replic
rate
larg
popul
size
reason
singl
rna
viru
popul
consist
multipl
slightli
differ
genom
sometim
refer
mutant
spectra
high
mutat
rate
rna
virus
increas
abil
virus
adapt
divers
host
interspeci
transmiss
event
potenti
caus
new
human
zoonot
diseas
howev
littl
known
particular
mutat
enabl
interspeci
transmiss
event
occur
coronavirus
particularli
adept
adapt
new
host
due
part
amaz
capac
genom
recombin
coronavirus
largest
genom
rna
virus
consist
kb
posit
sens
singlestrand
rna
although
recombin
lead
interspeci
transmiss
event
believ
case
sarscov
accumul
point
mutat
may
also
enabl
coronavirus
adapt
new
host
speci
coronavirida
subfamili
coronovirina
compos
three
genera
base
serolog
genet
characterist
alphacoronaviru
formerli
group
includ
virus
infect
pig
dog
cat
human
betacoronaviru
formerli
group
includ
bovin
bat
human
hors
pig
rodent
bat
virus
gammacoronaviru
formerli
group
consist
virus
adapt
bird
bovin
coronaviru
bcov
betacoronaviru
relat
sarscov
caus
diseas
human
least
one
occas
bcov
known
use
sialic
acid
bind
host
cell
although
second
receptor
may
involv
spike
protein
present
surfac
virion
determin
host
rang
tissu
tropism
coronvavirus
receptor
bind
domain
bcov
determin
recent
studi
peng
al
indic
fall
within
n
termin
domain
bcov
infect
may
caus
acut
sever
diarrhea
respiratori
symptom
cattl
especi
stress
condit
transport
subclin
infect
may
occur
healthi
cattl
bcov
isol
gener
obtain
inocul
nasal
fecal
sampl
infect
cattl
human
rectal
tumor
cell
cell
howev
genet
chang
viral
popul
allow
bovin
viru
adapt
human
cell
line
yet
defin
interest
understand
role
natur
viral
popul
divers
adapt
bcov
new
host
environ
particular
cell
type
may
enabl
viru
spread
via
respiratori
rout
caus
system
diseas
mutat
dynam
bcov
determin
serial
passag
bcov
nasal
sampl
human
bovin
lung
macrophag
cell
line
well
human
enter
cell
ebl
bomac
respect
consensu
subconsensu
variant
nucleotid
sequenc
cell
cultur
passag
sampl
compar
natur
unpassag
viral
popul
genom
region
analyz
includ
gene
involv
evas
host
innat
immun
respons
function
viral
replic
design
ncbi
bcov
refer
sequenc
involv
polymeras
fidel
spike
protein
gene
determin
host
rang
deep
sequenc
use
obtain
accur
pictur
viral
popul
divers
passag
cell
cultur
nasal
sampl
obtain
calv
test
bcov
rna
via
rtpcr
naturallyinfect
bcov
sampl
often
difficult
adapt
growth
cell
cultur
howev
essenti
use
naturallyinfect
sampl
rather
laboratori
adapt
viru
strain
isol
cell
cultur
like
result
adapt
mutat
present
natur
circul
viru
therefor
everi
step
viru
passag
protocol
optim
allow
greatest
chanc
viru
particl
recoveri
cell
cultur
passag
includ
incub
time
viru
cell
rna
extract
protocol
rtpcr
protocol
although
trypsin
shown
enhanc
infect
cell
use
infect
protocol
order
keep
protocol
ident
infect
enter
lung
macrophag
cell
line
three
nasal
sampl
highest
titer
determin
taqman
rtpcr
test
use
optim
protocol
laboratori
adapt
strain
nebraska
neb
includ
posit
control
cell
line
infect
infect
natur
bcov
nasal
sampl
product
three
five
cell
line
bomac
determin
rtpcr
compar
five
cell
line
product
infect
lab
adapt
strain
neb
determin
rtpcr
viral
growth
sustain
five
passag
cell
four
passag
bomac
viral
rna
detect
taqman
assay
passag
bomac
virus
except
neb
strain
sampl
viral
rna
extract
sampl
prior
passag
unpassag
viru
first
last
passag
experi
passag
bomac
passag
cell
approxim
kilobas
kb
bcov
kb
genom
amplifi
use
primer
set
design
conserv
region
genom
tabl
primer
set
use
amplifi
unpassag
passag
viral
rna
howev
case
primer
set
yield
pcr
product
suggest
chang
occur
primer
bind
region
passag
spike
protein
gene
consensu
sequenc
passag
unpassag
virus
compar
identifi
chang
characterist
serial
passag
phylogenet
analysi
consensu
sequenc
show
two
naturallyinfect
nasal
sampl
chang
much
gradual
compar
third
sampl
rapidli
chang
resembl
laboratori
adapt
neb
strain
one
passag
cell
cultur
regardless
cell
type
figur
sampl
form
two
major
cluster
one
includ
unpassag
sampl
group
one
includ
neb
refer
strain
sampl
passag
sampl
deriv
sampl
passag
group
p
region
genom
vari
number
observ
mutat
consensu
sequenc
spike
gene
show
mutat
due
passag
interestingli
consensu
sequenc
virus
passag
bomac
cell
chang
rapidli
compar
genom
virus
passag
cell
line
figur
surprisingli
passag
cell
cultur
consensu
sequenc
mani
viral
sampl
acquir
nt
insert
encod
amino
acid
ser
arg
arg
arg
locat
nt
spike
gene
wherea
none
unpassag
sampl
contain
insert
consensu
level
illustr
phylogram
spike
protein
figur
sampl
insert
gener
group
togeth
upper
clade
tree
although
point
mutat
differ
group
well
fouramino
acid
insert
locat
immedi
adjac
proteolyt
cleavag
site
spike
protein
subunit
spike
protein
respons
fusion
entri
viru
host
cell
addit
multipl
basic
residu
region
creat
furin
cleavag
site
may
serv
altern
trypsindepend
cleavag
spike
protein
data
sequenc
mean
show
insert
also
present
subconsensu
level
cellpassag
sampl
tabl
indepth
analysi
use
illumina
ultradeep
sequenc
mean
show
insert
present
low
number
unpassag
sampl
sometim
enrich
passag
cell
cultur
indic
possibl
role
cell
cultur
adapt
determin
insert
sequenc
present
neb
sampl
obtain
nvsl
propag
laboratori
second
sampl
strain
request
nvsl
unfortun
strain
longer
avail
due
gap
product
test
sampl
rna
nvsl
neb
stock
obtain
test
purpos
rna
sampl
test
use
taqman
pcr
assay
design
detect
insert
data
show
insert
present
approxim
consensu
level
rna
nvsl
tabl
insert
reach
consensu
passag
nasal
sampl
passag
sampl
passag
sampl
bomac
samplepassag
combin
present
subconsensu
level
tabl
nt
insert
present
bcov
sequenc
avail
genbank
neb
strain
sequenc
avail
genbank
genbank
data
typic
reflect
consensu
sequenc
present
sampl
possibl
insert
present
subconsensu
level
common
labadapt
strain
bcov
address
question
bcov
strain
mebu
obtain
bei
resourc
test
presenc
insert
use
taqman
pcr
assay
insert
detect
dilut
undilut
mebu
rna
even
though
mebu
polymeras
present
approxim
copi
per
ng
rna
four
addit
bovin
nasal
sampl
test
posit
presenc
bcov
polymeras
taqman
assay
test
presenc
insert
use
taqman
assay
polymeras
gene
detect
low
level
sampl
rang
copi
per
cdna
insert
detect
low
level
one
unpassag
sampl
addit
illumina
deep
sequenc
data
gener
unpassag
bcov
nasal
sampl
previou
studi
data
examin
found
insert
present
low
level
verifi
reproduc
rapid
enrich
insert
consensu
level
nasal
sampl
use
taqman
insert
assay
test
presenc
insert
second
sampl
pass
bomac
cell
avail
previou
experi
taqman
assay
detect
insert
sampl
approxim
number
polymeras
gene
thu
indic
enrich
process
reproduc
number
viral
genom
variant
nucleotid
polymorph
occur
subconsensu
level
vari
wide
sampl
tabl
figur
show
littl
correl
variant
count
coverag
suggest
wide
differ
variant
count
could
explain
variat
coverag
sequenc
increas
sensit
variant
detect
three
unpassag
sampl
sequenc
second
time
use
illumina
ga
iix
sequenc
sampl
also
resequenc
data
disagre
taqman
result
compar
data
illumina
sequenc
data
detect
substanti
variant
nasal
sampl
nasal
sampl
tabl
illumina
data
nasal
sampl
show
modest
increas
variant
count
compar
data
consist
fact
major
variant
nasal
sampl
occur
higher
frequenc
high
enough
detect
sequenc
measur
abund
variant
given
posit
genom
within
sampl
defin
frequenc
variant
percentag
map
read
overlap
queri
posit
contain
target
variant
divid
total
number
map
read
overlap
queri
posit
make
base
call
type
median
variant
frequenc
sampl
sampl
thu
increas
variant
count
obtain
illumina
sampl
reflect
presenc
larger
pool
variant
present
lower
frequenc
level
averag
fraction
sequenc
region
genom
contain
variant
data
illumina
data
analysi
restrict
base
consensu
nucleotid
call
consist
higher
coverag
sensit
associ
illumina
data
explor
possibl
subconsensu
variant
support
viru
adapt
new
cell
type
compar
consensu
sequenc
unpassag
parent
sampl
passag
descend
phylogram
gener
use
consensu
sequenc
figur
protein
studi
highlight
passag
sampl
differ
substanti
unpassag
parent
lower
clade
indic
cluster
neb
strain
upper
clade
figur
show
sampl
cluster
away
unpassag
parent
percentag
passag
consensu
snp
singl
nucleotid
polymorph
present
variant
unpassag
sampl
see
materi
method
detail
descript
method
use
rigor
differenti
mutat
attribut
sequenc
error
major
consensu
passag
snp
present
variant
respect
unpassag
parent
sampl
case
except
impact
low
variant
count
tabl
thu
result
sampl
support
hypothesi
mutat
present
passag
strain
select
preexist
pool
rather
de
novo
mutat
subsequ
popul
fixat
hypothes
mutat
signatur
genom
laboratori
passag
sampl
reflect
cell
passag
adapt
mutat
either
nonexist
exist
subconsensu
level
unpassag
sampl
increas
abund
cell
passag
may
eventu
reach
consensu
highli
passag
sampl
identifi
posit
bcov
genom
three
unpassag
sampl
consensu
snp
differ
consensu
snp
found
eight
neb
sampl
defin
upsnp
psnp
consensu
snp
found
unpassag
parent
sampl
highli
passag
neb
sampl
respect
use
sequenc
neb
pass
highlypassag
repres
psnp
found
alreadi
exist
variant
unpassag
sampl
nasal
sampl
respect
use
illumina
data
consist
result
found
persampl
basi
shown
figur
made
pairwis
comparison
earli
vs
late
passag
sampl
deriv
nasal
sampl
cell
line
exampl
compar
compar
pair
avail
analysi
cell
type
bomac
nasal
sampl
posit
posit
show
enrich
psnp
earli
late
passag
sampl
major
case
least
pair
passag
sampl
two
posit
locat
gene
locat
spike
gene
tabl
point
mutat
chang
upsnp
psnp
locat
nonsynonym
tabl
passag
marker
found
variant
unpassag
sampl
identifi
unpassag
sinc
sampl
passag
deriv
rapidli
chang
passag
resembl
neb
strain
surpris
acquir
neb
strain
snp
present
initi
unpassag
sampl
genet
chang
occur
deriv
sampl
show
less
clear
pattern
sinc
subset
sampl
acquir
neb
strain
snp
consensu
check
lack
neb
variant
unpassag
sampl
anomali
compar
variant
pool
passag
descend
neb
snp
inde
larg
increas
neb
strain
snp
exist
variant
passag
descend
compar
parent
sampl
suggest
snp
either
independ
acquir
singl
cell
passag
undetect
sequenc
origin
unpassag
sampl
seem
like
increas
number
serial
passag
would
result
sampl
acquir
neb
strain
snp
passag
associ
mutat
mutat
nonsynonym
locat
spike
gene
mutat
site
list
tabl
nonsynonym
mutat
transit
ts
transvers
tv
shown
tabl
structur
model
ntermin
part
receptor
bind
domain
spike
protein
passag
bcov
construct
use
system
base
homolog
sequenc
ident
spike
protein
murin
coronaviru
pdb
templat
shown
figur
least
nonsynonym
mutat
see
posit
color
green
tabl
occur
surfaceaccess
residu
receptor
bind
domain
one
surfac
expos
aminoacid
mutat
requir
transvers
aat
tct
one
nonsynonym
mutat
transvers
locat
buri
posit
spike
protein
given
nt
insert
major
passag
associ
point
mutat
locat
spike
protein
sought
determin
whether
passag
marker
part
passag
genotyp
whether
link
insert
haplotyp
open
sourc
softwar
shorah
use
carri
genotyp
reconstruct
shorah
estim
genet
divers
heterogen
sampl
deep
sequenc
data
previous
appli
estim
hiv
hepat
c
viru
quasispeci
given
two
posit
genom
shorah
return
genotyp
found
two
posit
base
read
overlap
region
posit
possibl
passag
marker
mutat
link
insert
genotyp
examin
check
linkag
snp
insert
nt
posit
read
overlap
two
closest
passag
marker
posit
divid
insertcontain
group
insertlack
group
separ
sampl
ten
sampl
insertlack
read
contain
upsnp
c
major
insertcontain
read
show
psnp
two
posit
howev
case
neb
passag
sampl
passag
sampl
nasal
sampl
differ
pattern
observ
although
insertlack
read
occur
low
level
continu
exclus
show
psnp
variant
major
genet
popul
nasal
sampl
lack
insert
genotyp
passag
descend
retain
minor
popul
insertlack
genom
contain
genotyp
ident
insert
contain
domin
genotyp
thu
appear
two
distinct
genotyp
circul
remain
unclear
whether
insertlack
passag
variant
nasal
sampl
neb
origin
pvariant
lost
insert
rather
origin
insert
lack
upvari
acquir
pvariant
mutat
independ
coronaviru
infect
mediat
spike
protein
consist
two
subunit
ntermin
subunit
ctermin
transmembran
subunit
although
subunit
coronavirus
mediat
receptor
bind
subunit
mediat
fusion
viral
envelop
host
cell
membran
potenti
effect
bcov
insert
subunit
region
spike
gene
includ
increas
host
cell
rang
via
trypsinindepend
fusion
host
cell
entri
due
creation
furin
cleavag
site
enhanc
bind
heparan
sulfat
host
cell
surfac
due
addit
multibas
region
although
locat
insert
subunit
may
decreas
influenc
insert
heparin
sulfat
bind
interest
note
presenc
basic
residu
present
passag
genotyp
may
impact
bind
heparin
sulfat
figur
studi
coronavirus
show
fusogen
activ
spike
protein
may
allow
trypsinindepend
entri
viru
varieti
cell
type
exampl
addit
multibas
motif
subunit
bcov
spike
protein
may
creat
trypsinindepend
spike
protein
activ
site
recent
propos
sarscov
watanab
et
al
gener
sarscov
construct
furin
site
sarscov
posit
shown
sarscov
activ
cell
surfac
trypsinindepend
manner
work
highlight
import
residu
context
sarscov
infect
posit
sarscov
residu
correspond
residu
passag
bcov
multipl
sequenc
align
show
arginin
residu
extrem
wellconserv
across
coronavirus
figur
interestingli
two
arginin
sarscov
construct
overlap
arginin
insert
identifi
passag
bcov
although
multibas
insert
may
enhanc
bind
bcov
divers
cell
type
via
bind
heparan
sulfat
host
cell
surfac
heparan
sulfat
bind
associ
viral
attenu
vivo
due
increas
clearanc
rate
may
provid
explan
rariti
insert
genotyp
naturallyinfect
sampl
addit
coronaviru
fixat
heparan
sulfat
surfac
macrophag
associ
increas
host
inflammatori
cytokin
respons
via
bind
tolllik
receptor
environment
factor
presenc
trypsinlik
enzym
bovin
airway
could
also
influenc
select
pressur
frequenc
genotyp
lack
insert
chouljenko
et
al
identifi
amino
acid
chang
spike
protein
gene
differenti
respiratori
bcov
rbcv
strain
enter
bcov
ebcv
strain
well
amino
acid
chang
virul
specif
mean
detect
extens
labpassag
strain
attenu
phenotyp
bovin
infect
data
show
rbcvspecif
chang
present
group
sampl
p
group
sampl
tabl
group
amino
acid
chang
also
correl
amino
acid
chang
consid
virul
marker
chouljenko
et
al
similarli
chang
identifi
studi
zhang
et
al
associ
virul
present
group
p
group
six
chang
nonconserv
reproduc
data
result
indic
laboratori
passag
caus
predict
chang
amino
acid
sequenc
although
rate
chang
observ
consensu
sequenc
differ
accord
cell
type
individu
sampl
number
amino
acid
chang
spike
protein
hypothes
involv
virul
tissu
tropism
viru
particular
amino
acid
chang
ser
group
ala
p
group
observ
amino
acid
directli
adjac
spike
protein
proteolyt
cleavag
site
serin
site
hypothes
associ
cell
fusion
data
indic
loss
serin
associ
gain
positivelycharg
insert
subunit
spike
protein
anoth
region
immedi
upstream
insert
suggest
fusogen
domain
parker
et
al
interestingli
nonconserv
amino
acid
chang
sequenc
nonpolar
amino
acid
ala
parker
et
al
gli
chouljenko
et
al
p
group
acid
amino
acid
asp
group
region
compos
almost
entir
nonpolar
amino
acid
addit
charg
residu
may
influenc
function
anoth
mutat
occur
amino
acid
part
heptad
repeat
domain
associ
class
fusion
protein
host
rang
case
gli
group
replac
asp
p
group
ultim
role
mutat
viral
phenotyp
need
confirm
use
revers
genet
use
high
throughput
sequenc
track
evolut
variant
genotyp
sever
passag
cell
line
identif
variant
deep
sequenc
multipl
bcov
sampl
point
rna
viru
rel
high
mutat
rate
howev
major
identifi
variant
detect
rel
low
abund
leav
open
question
function
signific
compar
consensu
point
mutat
variant
counterpart
use
way
find
variant
greater
potenti
function
signific
result
show
rather
de
novo
mutat
driver
genet
chang
consensu
popul
level
select
preexist
mutat
evid
major
case
presum
suffici
larg
popul
size
extend
evolut
novel
mutat
becom
bigger
factor
result
illustr
introduct
novel
mutat
nontrivi
process
moreov
result
indic
import
identifi
variant
popul
potenti
key
piec
inform
assess
viral
isol
would
like
adapt
genet
new
host
environ
nebraska
neb
strain
bcov
obtain
nvsl
nation
veterinari
servic
laboratori
ame
ia
use
refer
posit
control
cell
cultur
infect
molecular
assay
stock
neb
strain
receiv
nvsl
pass
time
bovin
turbin
embryon
kidney
cell
bcov
strain
mebu
obtain
bei
resourc
manassa
va
human
colorect
carcinoma
cell
cell
atcc
grown
advanc
dulbecco
minimum
essenti
medium
dmem
gibco
mm
lglutamin
gibco
iuml
streptomycin
gibco
supplement
heatinactiv
fetal
bovin
serum
fb
gibco
ebtr
bovin
embryon
tracheal
cell
atcc
human
lung
adenocarcinoma
cell
atcc
grown
eagl
minimum
essenti
medium
emem
gibco
mm
lglutamin
penicillinstreptomycin
supplement
heatinactiv
fb
human
acut
monocyt
leukemia
cell
atcc
bomac
bovin
macrophag
gift
dr
mark
est
univ
texa
medic
branch
grown
medium
gibco
mm
lglutamin
penicillinstreptomycin
supplement
heatinactiv
fb
human
alveolar
basal
epitheli
cell
obtain
nvsl
ebl
embryon
bovin
lung
cell
atcc
grown
minimum
essenti
medium
mem
gibco
mm
lglutamin
penicillinstreptomycin
supplement
heatinactiv
fb
cell
propag
optimum
cultur
medium
confluent
maintain
incub
cell
detach
passag
use
trypsinedta
gibco
except
cell
cell
maintain
either
addit
freshli
made
growth
medium
centrifug
resuspens
cell
fresh
medium
frequenc
bcov
infect
known
healthi
cattl
therefor
larg
number
calv
sampl
ensur
least
sever
posit
sampl
would
obtain
studi
approv
institut
anim
care
use
committe
lawrenc
livermor
nation
laboratori
protocol
number
approxim
nasal
cultur
swab
collect
calv
analyz
steril
polyest
swab
use
collect
nasal
sampl
place
ml
eagl
minimum
essenti
medium
gibco
transport
ice
back
laboratori
collect
nasal
swab
homogen
eagl
minimum
essenti
medium
supplement
antibioticantimycot
solut
gibco
sampl
suspens
clarifi
centrifug
minut
filter
filter
aliquot
store
first
group
cattl
test
hous
individu
outdoor
pen
dairi
farm
davi
ca
like
calv
rel
stress
due
sever
day
period
cold
raini
winter
weather
nasal
swab
obtain
anim
anim
posit
bcov
infect
determin
rtpcr
assay
anoth
group
calv
test
period
rel
mild
winter
weather
calv
part
herd
includ
cowcalf
pair
graze
pastur
nasal
swab
obtain
calv
brand
vaccin
procedur
none
sampl
posit
bcov
rna
rtpcr
assay
confluent
cell
line
plate
infect
nasal
sampl
dilut
mem
viru
sampl
incub
hour
inoculum
remov
cell
rins
twice
steril
pb
case
cell
cell
pellet
step
appropri
media
ad
cell
line
supernat
infect
cell
transfer
fresh
cell
monolay
everi
h
neb
strain
stock
use
posit
control
infect
cell
line
sampl
homogen
trizol
reagent
invitrogen
follow
manufactur
protocol
except
incub
perform
instead
room
temperatur
primer
design
amplifi
eight
region
kb
amplifi
region
overlap
allow
genotyp
reconstruct
primer
design
sensit
target
strain
variant
possibl
still
specif
enough
crossreact
nontarget
primer
set
set
genom
region
test
select
two
best
perform
primer
set
amplif
region
tabl
rna
convert
cdna
use
random
hexam
superscript
iii
firststrand
synthesi
system
rtpcr
invitrogen
accord
manufactur
instruct
case
viral
titer
appear
low
rna
ad
rt
mixtur
pcr
primer
condit
use
detect
bcov
rna
present
nasal
sampl
describ
cho
et
al
high
fidel
phusion
polymeras
new
england
biolab
use
amplifi
region
bcov
genom
sequenc
follow
manufactur
instruct
use
reaction
cdna
templat
primer
set
use
genom
amplif
list
tabl
pcr
condit
consist
min
follow
cycl
min
sampl
amplifi
primer
set
product
pool
purifi
use
qiaquick
pcr
purif
kit
qiagen
quantifi
amplicon
submit
sequenc
dna
sequenc
center
brigham
young
univers
subset
amplicon
sequenc
illumina
ga
iix
sequenc
eureka
genom
hercul
ca
raw
sequenc
read
gener
experi
read
align
refer
sequenc
avail
ftp
taqman
assay
qrtpcr
design
detect
region
viru
polymeras
gene
well
region
spike
gene
found
site
nucleotid
nt
insert
sampl
rna
extract
revers
transcrib
describ
taqman
assay
perform
aliquot
cdna
reaction
mix
use
ht
sequenc
detect
system
appli
biosystem
taqman
univers
pcr
master
mix
appli
biosystem
amplif
viral
cdna
plasmid
clone
insert
amplif
larger
region
polymeras
gene
spike
insert
region
use
gener
standard
curv
quantit
taqman
primer
probe
amplif
polymeras
gene
fwd
ccatgtgtcatgcattggatt
rv
caccgatcatcctgacaatca
probe
ccgtgttaggatggtatggcatactccagtg
taqman
primer
probe
amplif
spike
insert
region
fwd
ggttgtttaggaagcggttg
rv
agcctcaacgaaaccgacat
probe
ccggcgtagaagtagatctgctatagaggattt
cycl
paramet
min
min
cycl
sec
min
determin
error
rate
pcr
amplif
sequenc
process
sequenc
control
plasmid
construct
insert
kb
fragment
bcov
polymeras
gene
sequenc
plasmid
use
invitrogen
clone
kit
sequenc
plasmid
region
sanger
sequenc
determin
sequenc
insert
prior
pcr
amplif
illumina
sequenc
plasmid
insert
amplifi
use
protocol
viral
sampl
submit
illumina
sequenc
along
viral
pcr
product
sequenc
control
use
model
error
measur
observ
miscal
rate
nonconsensu
base
sampl
consensu
sequenc
iter
construct
first
map
close
relat
refer
sequenc
genbank
identifi
construct
new
consensu
sequenc
map
read
new
consensu
sequenc
refer
order
increas
number
map
read
reduc
potenti
align
error
repeat
process
consensu
sequenc
converg
singl
valu
follow
error
filter
rule
use
preclud
read
align
consensu
sequenc
contribut
base
call
given
genom
posit
due
likelihood
error
indel
align
read
present
within
five
base
queri
base
posit
within
read
must
least
five
base
away
end
read
avoid
misalign
variant
call
must
observ
read
sequenc
strand
avoid
miscal
misalign
adjac
base
read
must
agre
consensu
sequenc
thu
filter
adjac
variant
mutat
rule
elimin
larg
percentag
erron
variant
call
control
sequenc
thu
rather
reli
uniform
observ
error
rate
cover
posit
control
use
averag
per
posit
per
base
call
error
rate
restrict
case
variant
base
call
identifi
reason
altern
approach
would
lead
artifici
lower
error
rate
includ
case
variant
base
call
observ
led
observ
per
genom
posit
per
base
call
condit
error
rate
reflect
averag
percentag
read
report
erron
subconsensu
base
call
posit
genom
error
rate
condit
case
nonconsensu
base
call
made
rather
error
rate
averag
base
call
includ
nosubconsensu
mutat
attempt
due
read
map
qualiti
control
exclus
rule
subsequ
lack
observ
variat
sinc
least
order
magnitud
greater
mutat
frequenc
expect
coronavirus
necessari
observ
subconsensu
mutat
multipl
sequenc
read
ensur
mutat
occur
high
enough
frequenc
sampl
unlik
attribut
sequenc
error
determin
minimum
number
read
need
support
presenc
subconsensu
mutat
binomi
signific
test
describ
eriksson
et
al
appli
approach
assum
binomi
error
distribut
given
sequenc
coverag
amount
number
read
contain
subconsensu
mutat
would
expect
assum
sequenc
error
rate
calcul
mutat
occur
number
read
exce
amount
pvalu
appli
bonferonni
correct
mutat
infer
unlik
attribut
sequenc
error
detect
sensit
therefor
coverag
sequenc
error
depend
coverag
mutat
would
requir
occur
read
constitut
percent
total
least
two
read
occur
opposit
strand
illumina
sequenc
carri
four
sampl
tabl
use
illumina
pairedend
technolog
read
pair
length
bp
creat
overlap
region
approxim
bp
although
pairedend
technolog
origin
intend
creat
read
pair
gap
known
size
templat
cut
length
much
longer
read
length
eg
bp
templat
bp
read
known
gap
size
facilit
postsequenc
align
particularli
use
complex
nonvir
genom
templat
use
closer
read
length
pairedend
technolog
creat
read
pair
signific
region
overlap
overlap
read
pair
essenti
provid
anoth
mechan
error
check
read
pair
came
templat
therefor
perfectli
complementari
disagr
read
pair
would
due
sequenc
error
disagr
overlap
read
pair
use
correl
mismatch
rate
sequenc
gener
qualiti
score
cutoff
select
minimum
base
call
qualiti
score
limit
mismatch
error
rate
maintain
high
amount
sequenc
coverag
base
call
support
read
pair
minimum
qualiti
score
use
infer
affect
erorr
rate
control
sequenc
found
rate
maxim
percentag
read
observ
disagre
posit
control
data
error
rate
use
input
binomi
signific
test
determin
minimum
number
read
need
separ
sequenc
error
true
genet
variat
open
sourc
softwar
shorah
use
carri
genotyp
reconstruct
pyrosequenc
data
obtain
bcov
sampl
sampl
nasal
sampl
neb
strain
respect
across
sampl
uniqu
base
sequenc
cover
spike
protein
posit
refer
genom
genbank
access
number
averag
coverag
four
protein
region
standard
deviat
coverag
four
protein
region
henc
coverag
genom
highest
variabl
among
four
protein
four
sampl
also
sequenc
use
illumina
obtain
deeper
coverag
clarifi
differ
sampl
tabl
summar
count
variant
detect
averag
per
base
read
coverag
sampl
includ
number
genom
posit
greater
use
minimum
coverag
cutoff
consensu
base
call
primer
region
exclud
avoid
fals
posit
variant
call
nonspecif
primer
bind
averag
kb
consensu
sequenc
recov
